Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis
Abroad (travel likely)RecruitingPHASE2
Conditions
Primary Myelofibrosis · Secondary Myelofibrosis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Contact: Principal Investigator (Rachel B. Salit)
Study leads
Rachel B. Salit
Principal Investigator
Fred Hutch/University of Washington Cancer Consortium